One out of three sexually active older adults infected with HIV has unprotected sex, according to a study by Ohio University researchers. A survey of 260 HIV-positive older adults found that of those having sex, most were male, took Viagra and were in a relationship.
AIDS Healthcare Foundation (AHF), the US? largest HIV/AIDS healthcare, prevention and education provider, which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, chastised US drug giant, Abbott Laboratories for its ?quid pro quo? offer earlier today to the Government of Thailand to lower its price for Abbott?s key AIDS drug, Aluvia (a heat-stable tablet version of Kaletra) to approximately USD$1000 per patient per year?an offer contingent upon Abbott?s demand that Thailand immediately halt issuing compulsory licenses for the generic manufacture of this lifesaving drug.
Researchers from Massachusetts General Hospital (MGH) have found that infection with HIV, the virus that causes AIDS, is also associated with increased risk of myocardial infarction or heart attack.
Many patients diagnosed with HIV in the 1980s and 1990s have survived and now are entering their golden years. AIDS cases among the over-50 crowd reached 90,000 in 2003, and according to the Centers for Disease Control and Prevention, will account for half of all HIV/AIDS cases in the United States by 2015.
German researchers have found a natural component of human blood that block the HIV virus from infecting cells, and would be more potent to fight the HIV virus.
The United Nations Development Programme (UNDP) is partnering with basketball star Yao Ming, Chinese actor Pu Cunxin, the National Basketball Association (NBA) and the non-governmental organization (NGO) Aaron Diamond AIDS Research Center to minimize the stigma attached to those living with HIV/AIDS in China.
Some HIV-infected patients in Uganda who self paid for their antiretroviral medications experienced interruptions in drug supply due to either financial demands or supply logistical disruptions. These treatment interruptions led to the development of resistance to antiretroviral medications in patients.
Access to antiretroviral therapy for advanced HIV infection in low- and middle-income countries continued to grow throughout 2006, with more than 2 million people living with HIV/AIDS receiving treatment in December 2006, a 54% increase over the 1.3 million people on treatment one year earlier in these countries.
A new study has pinpointed a natural ingredient of human blood that effectively blocks HIV-1, the virus predominantly responsible for human AIDS, from infecting immune cells and multiplying.
Indian government committed to providing second-line drugs free of cost to people who develop resistance to the existing treatment for HIV /AIDS.